• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
WANG Shanshan, LIANG En, WANG Xiaoling, MEI Dong, WANG Zengming, ZHENG Aiping. Current situation and prospect of 3D printing technology in pharmaceutical preparations[J]. Journal of China Pharmaceutical University, 2023, 54(1): 15-22. DOI: 10.11665/j.issn.1000-5048.20221130002
Citation: WANG Shanshan, LIANG En, WANG Xiaoling, MEI Dong, WANG Zengming, ZHENG Aiping. Current situation and prospect of 3D printing technology in pharmaceutical preparations[J]. Journal of China Pharmaceutical University, 2023, 54(1): 15-22. DOI: 10.11665/j.issn.1000-5048.20221130002

Current situation and prospect of 3D printing technology in pharmaceutical preparations

Funds: This work was supported by the National Natural Science Foundation of China (No.82073793)
More Information
  • Received Date: November 29, 2022
  • Revised Date: March 01, 2023
  • With the rapid advancement of science and technology, the application of 3D printing technology for personalized drug manufacturing is becoming increasingly sophisticated.Compared to traditional manufacturing technology, 3D printing can easily customize preparations with specific sizes, shapes and release behaviors for personalized drug use.This review summarizes the principles of several 3D printing technologies commonly used in drug manufacturing, lists the unique advantages and application examples of 3D printing technology for pharmaceutical preparation, analyses the current research status and development trends of the global industry of drug 3D printing, and summarizes the current problems and challenges facing drug 3D printing, aiming to provide some guidance for researchers of 3D printed drugs.
  • [1]
    . Int J Mach Tools Manuf,2000,40(3):363-379.
    [2]
    Pavan Kalyan BG,Kumar L. 3D printing:applications in tissue engineering,medical devices,and drug delivery[J]. AAPS PharmSciTech,2022,23(4):92.
    [3]
    Sood AK,Ohdar RK,Mahapatra SS. Parametric appraisal of mechanical property of fused deposition modelling processed parts[J]. Mater Des,2010,31(1):287-295.
    [4]
    Park BJ,Choi HJ,Moon SJ,et al. Pharmaceutical applications of 3D printing technology:current understanding and future perspectives[J].J Pharm Investig,2019,49(6):575-585.
    [5]
    Wang X,Zhang C,Ping QN. Advances of 3D printing technology in advanced pharmaceutical preparations[J]. J China Pharm Univ(中国药科大学学报),2016,47(2):140-147.
    [6]
    Heller C,Schwentenwein M,Varga F,et al. Additive manufacturing technologies for the 3D fabrication of biocompatible and biodegradable photopolymers[J]. MRS Online Proc Libr,2009,1239(1):805.
    [7]
    Sen K,Mehta T,Sansare S,et al. Pharmaceutical applications of powder-based binder jet 3D printing process — A review[J]. Adv Drug Deliv Rev,2021,177:113943.
    [8]
    Wang SS,Chen XJ,Han XL,et al. A review of 3D printing technology in pharmaceutics:technology and applications,now and future[J]. Pharmaceutics,2023,15(2):416.
    [9]
    Seoane-Via?o I,Januskaite P,Alvarez-Lorenzo C,et al. Semi-solid extrusion 3D printing in drug delivery and biomedicine:Personalised solutions for healthcare challenges[J]. J Control Release,2021,332:367-389.
    [10]
    Quodbach J,Bogdahn M,Breitkreutz J,et al. Quality of FDM 3D printed medicines for pediatrics:considerations for formulation development,filament extrusion,printing process and printer design[J]. Ther Innov Regul Sci,2022,56(6):910-928.
    [11]
    Melocchi A,Uboldi M,Cerea M,et al. A graphical review on the escalation of fused deposition modeling (FDM) 3D printing in the pharmaceutical field[J]. J Pharm Sci,2020,109(10):2943-2957.
    [12]
    Deshmane S,Kendre P,Mahajan H,et al. Stereolithography 3D printing technology in pharmaceuticals:a review[J]. Drug Dev Ind Pharm,2021,47(9):1362-1372.
    [13]
    Xu X,Awad A,Robles-Martine P,et al. Vat photopolymerization 3D printing for advanced drug delivery and medical device applications[J]. J Control Release,2021,329:743-757.
    [14]
    Guerra AJ,Lara-Padilla H,Becker ML,et al. Photopolymerizable resins for 3D-printing solid-cured tissue engineered implants[J]. Curr Drug Targets,2019,20(8):823-838.
    [15]
    Goyanes A,Madla CM,Umerji A,et al. Automated therapy preparation of isoleucine formulations using 3D printing for the treatment of MSUD:first single-centre,prospective,crossover study in patients[J]. Int J Pharm,2019,567:118497.
    [16]
    Zheng Y,Deng FH,Wang B,et al. Melt extrusion deposition (MEDTM) 3D printing technology — A paradigm shift in design and development of modified release drug products[J]. Int J Pharm,2021,602:120639.
    [17]
    Smith DM,Kapoor Y,Klinzing GR,et al. Pharmaceutical 3D printing:design and qualification of a single step print and fill capsule[J]. Int J Pharm,2018,544(1):21-30.
    [18]
    Jacob S,Nair AB,Patel V,et al. 3D printing technologies:recent development and emerging applications in various drug delivery systems[J]. AAPS PharmSciTech,2020,21(6):220.
    [19]
    Wang ZM,Han XL,Chen RX,et al. Innovative color jet 3D printing of levetiracetam personalized paediatric preparations[J]. Asian J Pharm Sci,2021,16(3):374-386.
    [20]
    Kozakiewicz-Lata?a M,Nartowski KP,Dominik A,et al. Binder jetting 3D printing of challenging medicines:from low dose tablets to hydrophobic molecules[J]. Eur J Pharm Biopharm,2022,170:144-159.
    [21]
    Chang SY,Jin J,Yan J,et al. Development of a pilot-scale HuskyJet binder jet 3D printer for additive manufacturing of pharmaceutical tablets[J]. Int J Pharm,2021,605:120791.
    [22]
    Herrada-Manchón H,Rodríguez-González D,Alejandro Fernández M,et al. 3D printed gummies:personalized drug dosage in a safe and appealing way[J]. Int J Pharm,2020,587:119687.
    [23]
    Tagami T,Ito E,Kida R,et al. 3D printing of gummy drug formulations composed of gelatin and an HPMC-based hydrogel for pediatric use[J]. Int J Pharm,2021,594:120118.
    [24]
    Han XL,Kang DZ,Liu BS,et al. Feasibility of developing hospital preparation by semisolid extrusion 3D printing:personalized amlodipine besylate chewable tablets[J]. Pharm Dev Technol,2022,27(2):164-174.
    [25]
    Zhu CX,Tian Y,Zhang EH,et al. Semisolid extrusion 3D printing of propranolol hydrochloride gummy chewable tablets:an innovative approach to prepare personalized medicine for pediatrics[J]. AAPS PharmSciTech,2022,23(5):166.
    [26]
    Yu DG,Yang XL,Huang WD,et al. Tablets with material gradients fabricated by three-dimensional printing[J]. J Pharm Sci,2007,96(9):2446-2456.
    [27]
    Yu DG,Liu J,Yang Y,et al. Studies on preparation of controlled-release delivery systems with drug gradients using three dimensional printing technique[J]. Chin Pharm J(中国药学杂志),2006,41(14):1080-1083.
    [28]
    Khaled SA,Burley JC,Alexander MR,et al. 3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles[J]. J Control Release,2015,217:308-314.
    [29]
    Hong XX,Han XL,Li XF,et al. Binder jet 3D printing of compound LEV-PN dispersible tablets:an innovative approach for fabricating drug systems with multicompartmental structures[J]. Pharmaceutics,2021,13(11):1780.
    [30]
    Yadav V,Sharma PK,Murty US,et al. 3D printed hollow microneedles array using stereolithography for efficient transdermal delivery of rifampicin[J]. Int J Pharm,2021,605:120815.
    [31]
    Economidou SN,Pere CPP,Reid A,et al. 3D printed microneedle patches using stereolithography (SLA) for intradermal insulin delivery[J]. Mater Sci Eng C Mater Biol Appl,2019,102:743-755.
  • Related Articles

    [1]LAN Aili, LIU Gang, WU Chaoran, LIAO Hong. Research progress of integrated stress response in central nervous system diseases[J]. Journal of China Pharmaceutical University, 2024, 55(2): 194-201. DOI: 10.11665/j.issn.1000-5048.2023112302
    [2]FENG Wanting, DENG Yaochen, ZHANG Hui, LI Meng, WANG Zengming, ZHENG Aiping. Research progress of taste masking and evaluation technology of medicine[J]. Journal of China Pharmaceutical University, 2023, 54(4): 410-420. DOI: 10.11665/j.issn.1000-5048.20221106002
    [3]WAN Li, SUN Jinnan, DING Zuoqi, HAO Haiping. Research on the development of bio-pharmaceutical industry integration and collaborative innovation in the Yangtze River Delta under the mode of Industry-University-Research cooperation[J]. Journal of China Pharmaceutical University, 2022, 53(6): 742-752. DOI: 10.11665/j.issn.1000-5048.20220614
    [4]ZHAO Yifei, GENG Xin, XU Lihua, OU Ting, ZHANG Ning. Considerations on the chemistry, manufacture and control requirements for conditional marketing authorization drugs in China[J]. Journal of China Pharmaceutical University, 2021, 52(5): 636-642. DOI: 10.11665/j.issn.1000-5048.20210518
    [5]HU Wanwan, DING Xuefeng, CAI Yanfei, CHEN Yun, DUAN Zuoying, JIN Jian, LI Huazhong. Site-specific integration and stable expression of exogenous protein at a novel site on CHO cell chromosome[J]. Journal of China Pharmaceutical University, 2021, 52(4): 487-495. DOI: 10.11665/j.issn.1000-5048.20210412
    [6]GONG Siman, LAN Siyi, LI Jing, SUN Minjie. Application of iron oxide magnetic nanoparticles in tumor theranostics[J]. Journal of China Pharmaceutical University, 2019, 50(5): 531-539. DOI: 10.11665/j.issn.1000-5048.20190504
    [7]WANG Zian, LIU Yang, WANG Peng, JIANG Yifei, JI Min. Preparation, in vitro imaging and antitumor activity of the second near-infrared imaging drug-loaded liposomes[J]. Journal of China Pharmaceutical University, 2019, 50(4): 438-443. DOI: 10.11665/j.issn.1000-5048.20190408
    [8]XING Xiaoqing, BU Xiumin, CHU Yanan, ZOU Bingjie, SONG Qinxin, ZHOU Guohua. Genotype method for SNPs related to individualized aspirin treatment based on pyrosequencing technology[J]. Journal of China Pharmaceutical University, 2017, 48(5): 577-582. DOI: 10.11665/j.issn.1000-5048.20170512
    [9]TANG Linfang, ZHANG Ziqiang, SU Rina, HE Shuwang, YAO Jing. Advances in taste-masking technology of oral paediatric medicine[J]. Journal of China Pharmaceutical University, 2017, 48(2): 135-141. DOI: 10.11665/j.issn.1000-5048.20170202
    [10]WANG Xue, ZHANG Can, PING Qineng. Advances of 3D printing technology in advanced pharmaceutical preparations[J]. Journal of China Pharmaceutical University, 2016, 47(2): 140-147. DOI: 10.11665/j.issn.1000-5048.20160203
  • Cited by

    Periodical cited type(1)

    1. 马小翔,马泽源,刘亚月,周龙建,和羿帆,张翼. 仿突变生物合成调控对土曲霉C23-3次生代谢产物的影响. 生物技术通报. 2024(08): 275-287 .

    Other cited types(0)

Catalog

    Article views (1111) PDF downloads (823) Cited by(1)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return